The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
We will determine if linezolid inhibits cellular activation and production of
pro-inflammatory cytokines, providing mechanistic rationale for its clinical efficacy and the
justification for further investigations in S. Aureus sepsis.